Thursday, October 11, 2007

A Function for the Appendix?

It has long been thought that the small blind-ended pouch near the end of the small intestine called the appendix is vestigial, i.e. it no longer serves any useful function in humans. But now scientists at Duke University hypothesize that the appendix may indeed still have a function. In a September 7 article online in the Journal of Theoretical Biology, the researchers speculate that the appendix serves as a reservoir (or safe haven) for “good” bacteria in the event that a severe bout of diarrhea flushes out most of the bacteria in the small and large intestines. After the diarrhea has passed, according to the scientists, the bacteria in the appendix could emerge to repopulate the intestines.

It’s an interesting thought, but this is speculation, not yet proved. The Journal of Theoretical Biology is a vehicle for ideas, not hard scientific data. My question would be if the appendix does serve a useful function, why don’t most animals have one? (Apparently only humans, rabbits, and two species of marsupials have an appendix.) An admittedly equally speculative explanation might be that while the appendix does harbor bacteria that help repopulate the gut after a bout of diarrhea in humans, that function is not so significant that it confers significant survival value any more. In other words, the appendix ultimately still may be considered vestigial.

The concept of survival value of a given structure or function is an important one for students to understand when discussing evolution, of course.

Monday, October 8, 2007

Breast Cancer Around the World

The cover story in this week’s issue of Time magazine (Oct. 15) is about the worldwide incidence of breast cancer. The article discusses how the economic situation in different countries affects the likelihood of screening for breast cancer and the probability that the cancer will be adequately treated once it is detected. The reasons for a failure to detect and treat breast cancers are different in different countries, but they include a shortage of doctors, diagnostic equipment, and x-ray film; the high cost of treatment relative to income; and the inability to reach a medical facility because of the lack of transportation.

Aside from the usual genetic influences, students might be interested to learn that cultural differences also influence the diagnosis and treatment of breast cancer. The article points out that in some countries, women are afraid to admit to having breast cancer out of fear that their husbands will leave them or that their daughters will be shunned by prospective marriage partners. Diet, too, has a significant effect, for reasons pointed out in the article. And finally, there is just plain ignorance about the disease – in one instance, a woman who had an obviously-visible tumor admitted that she had not been diagnosed earlier because it didn’t hurt. Clearly, the fight against breast cancer will need to be fought differently from country to country.

Monday, October 1, 2007

DNA Evidence Exonerates the Innocent

More than 300 persons convicted of rape or murder between 1989 and 2003 were later exonerated by new DNA or other evidence that proved their innocence, according to a study by a University of Michigan Law School professor (Samuel R. Gross, et. al. Exonerations in the United States 1989-2003. Journal of Criminal Law & Criminology 95:523-560, 2005.) In most cases their wrongful convictions were at least partially due to false identification by eyewitnesses. How many persons were erroneously convicted or even put to death in the past? We may never know.

The certain knowledge (with the help of DNA evidence) that mistakes were made in the past is fueling widespread reform of our criminal justice system, and thousands of innocent convicts may have their second day in court as a result. Its also prompting legal changes, including requirements in many states that confessions be recorded (to reduce the number of false confessions), and that informants’ testimony be corroborated before it can be used in a courtroom. States are also tightening up their procedures for how witnesses identify suspects in lineups and in photos.

On page 468 of Human Biology 5th ed. I describe the scientific basis for how a DNA sample is used to identify a particular individual. It's nice to see that its being used to protect the innocent, as well as convict the guilty.

Thursday, September 27, 2007

Body Size and Athletic Ability

According to an article in the on-line version of The New York Times today (“Bigger is Better, Except When It’s Not”), world-class rowers usually are big. Swimmers are tall. Distance runners are small and light. It’s all according to the rules of physics, exercise researchers say.

Previously I speculated that in a high-tech future world, children and their parents will be able to choose what sports the child is most likely to excel in based on hard scientific evidence (see the Directions in Science feature in Human Biology 5th ed., p. 132). Apparently some of the evidence is now known. But this does not mean that size, body form, and muscle biochemistry are all that matter. As the experience of Lance Armstrong has shown, good training and desire also count for something, too. Unless you aspire to be the best in the world, go out and do what you enjoy!

Tuesday, September 18, 2007

Artic Ice Loss Accelerates

The artic ice cap may be melting much faster than previously thought, according to scientists from the National Oceanic and Atmospheric Administration (NOAA). The scientists tested 20 different climate change computer models for their ability to replicate the sea ice conditions that actually existed between 1979 and 1999. After discarding the models that couldn’t accurately replicate the actual data, they used the remaining models to predict the artic ice melt to 2050. They report that the arctic ice cap may shrink by more than 40% by 2050, even if atmospheric carbon dioxide levels remain where they are today. But it's more likely that carbon dioxide levels will continue to rise, given our appetite for fossil fuels. The original article is published in the September 8 issue of Geophysical Research Letters.

A major loss of arctic ice would be bad news not just for polar bears, but for marine ecosystems in general. The winners: oil and gas companies would be able to explore more of the arctic sea bed for new sources of oil and gas, and ships might be able to use northern shipping routes between the Atlantic and Pacific during the summer months.

Note added Sept. 28: The Oct. 1 issue of Time magazine has a cover story which discusses the political and economic implications of the loss of arctic ice due to global warming. Apparently, nations are rushing to lay claim to the land (and mineral resources) previously under the ice, and shipping companies are eagerly awaiting the time when the Northwest Passage is open, at least for some of the year.

Wednesday, September 12, 2007

New Twist on Steroid Use in Baseball

According to a report on CNN’s Sports Illustrated website (SI.com) this week, three major-league baseball players received shipments of banned performance-enhancing (anabolic) steroids over several years. The report cites records obtained from unnamed sources. Although Major League Baseball has asked to talk to the players, none of the three has yet tested positive for steroids.

Huh? Perhaps we’ll hear a variation of the old “I smoked but I didn’t inhale” defense - “I bought them, but I never used them…”.

Anti-doping experts believe that players may be escaping detection by using human growth hormone in conjunction with very small doses of performance-enhancing steroids such as testosterone. Although there is no reliable test for exogenous human growth hormone, its use is banned by Major League Baseball.

The use of anabolic steroids in sports is discussed in Human Biology, 5th ed., pp. 134-135.

Friday, September 7, 2007

Merck Avoids a Class-Action Lawsuit Over Vioxx

Yesterday the New Jersey Supreme Court rejected a class-action lawsuit brought against Merck by a union health plan. The International Union of Operating Engineers Local 68 in Caldwell, N.J. was seeking a class-action lawsuit representing all of the insurance companies nationwide that had ever paid for Vioxx prescriptions as part of their health care plans. The court ruled that a single nationwide class-action lawsuit was not appropriate under the circumstances. Each insurance company will now have to sue Merck on their own (or not).

The ruling is a victory for Merck. However, Merck still faces an estimated 27,000 lawsuits from individual patients who claim that Vioxx causes strokes and heart attacks, and that the company knew it long before the drug was pulled from the market. Merck has vowed to fight each and every lawsuit one at a time. So far the strategy is working – Merck has won nine and lost five. At this rate, most of the patients will be dead from other causes long before they ever see a dime from Merck.

By the way, remember Mr. Leonell Garza, the 71-year-old man described in the Current Issue feature in Human Biology, 5th ed. (pp. 182-183) whose family was suing Merck for $1 billion in damages? A Texas jury awarded the family $32 million, but that had to be reduced to $7.75 million by Texas law. Merck is appealing. Stay tuned!